The data has been compiled from various sources and might have small difference but overall theme is to subscribe or not — we will focus on that
Tarsons Products IPO– Tarsons Products Limited is a leading Indian life sciences company with more than three decades of experience in the production and supply of labware products.
Business — The company manufactures a range of quality labware products that helps advance scientific discovery and improve healthcare systems. The company’s product portfolio is classified into three broad categories including consumables, reusables. These Products are used in various laboratories across research organizations, academic institutes, pharmaceutical companies, Contract Research Organizations (CRO), diagnostic companies, and hospitals.
Region of Operation -Company has 5 manufacturing facilities located in West Bengal spread across approximately 20,000 sq. mts of area. The company has a strong distribution network across India comprising of over 141 authorized distributors as of March 31, 2021 and supplies its products to more than 40 countries.
Also READ : NYKAA IPO : SUBSCRIBE OR NOT
Also Read : Latent View IPO : Subscribe or NOT
Offer purpose — The IPO comprises a fresh issue of equity shares up to ₹150 crore and an offer for sale (OFS) of ₹850 crore by existing shareholders and promoters. Company is planning to use IPO for Repayment/prepayment of all or certain of company’s borrowings; Funding a part of the capital expenditure for new manufacturing facility at Panchla, West Bengal (proposed expansion) and General corporate purposes
High Import dependency
Competition with MNC players
Environmental concern on Plastics
Regional concentration of plants
Leading supplier of life sciences products
Extensive product offering
Large addressable market of life sciences industry
Well-equipped and automated manufacturing facilities
Strong sales and distribution network
Experienced Promoter backed by a strong management team
Company is vertically integrated and equipped with automated support systems that help the company in maintaining quality, increasing productivity, and reducing costs. Its key manufacturing facilities are ISO 9001:2015 and ISO 13485:2016/NS-EN ISO 13485:2016 certified. Company is poised for bright prospects ahead. It is expanding to meet the rising demand for its products.
Valuations are reasonable looking at future. In short term, Price looks expensive
Should we apply?
For medium to long term, prospects looks bright with good set of customers and looking at no listed peers, may be advantage to subscribe
One must apply if they can held this stock patiently and not looking for immediate returns
In case you have any questions/ queries, please feel free to reach me through Contact Form
Do spread the word among your peers, family members or anyone who can benefit from this blog and asked them to subscribe. But be selfish and take care of yourself first by subscribing before they do.
Enjoy the day and your life. Don’t forget, we are alone in this grand universe and may not get a chance to live again.
3 thoughts on “Tarsons products IPO : Subscribe or NOT?”